Aerovate Therapeutics, Inc. Expected to Earn Q3 2023 Earnings of ($0.65) Per Share (NASDAQ:AVTE)

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]

Related Keywords

United States ,Switzerland ,Swiss ,Timothyp Noyes ,Benjamint Dake , ,Aerovate Therapeutics Company Profile ,Cheyne Capital Management United Kingdom ,Swiss National Bank ,Securities Exchange Commission ,Nasdaq ,Driehaus Capital Management ,Great Point Partners ,Crossover Management ,Aerovate Therapeutics Inc ,Aerovate Therapeutics ,Free Report ,Aerovate Therapeutic ,Get Free Report ,National Bank ,Capital Management United Kingdom ,Point Partners ,Exchange Commission ,Aerovate Therapeutics Daily ,Nasdaq Avte ,Navte ,Medical ,Earnings Estimates ,Wedbush ,